Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
12.81
0.00 (0.00%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Design Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2019
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2019
Net Income
-69.71-69.79-49.59-66.86-63.31-35.53
Upgrade
Depreciation & Amortization
0.620.620.60.540.410.13
Upgrade
Loss (Gain) From Sale of Investments
-2.34-3.25-6.2-6.08-1.4-0.08
Upgrade
Stock-Based Compensation
14.9314.5513.0713.0910.934.69
Upgrade
Other Operating Activities
0.480.410.010.030.060.02
Upgrade
Change in Accounts Payable
2.284.49-1.22-1.255.392.41
Upgrade
Change in Other Net Operating Assets
-0.26-1.380.231.97-3.39-1.02
Upgrade
Operating Cash Flow
-54-54.36-43.11-58.56-51.32-29.38
Upgrade
Capital Expenditures
-0.12-0.19-0.34-0.26-0.92-1.54
Upgrade
Sale of Property, Plant & Equipment
----0.04-
Upgrade
Investment in Securities
7.5823.1144.352.79-220.11-52.11
Upgrade
Investing Cash Flow
7.4522.9143.9652.54-220.99-53.64
Upgrade
Issuance of Common Stock
45.6525.740.510.720.66254.5
Upgrade
Other Financing Activities
-----0.43-
Upgrade
Financing Cash Flow
45.6525.740.510.720.24379.21
Upgrade
Net Cash Flow
-0.9-5.711.36-5.3-272.07296.19
Upgrade
Free Cash Flow
-54.12-54.55-43.45-58.82-52.24-30.92
Upgrade
Free Cash Flow Per Share
-0.93-0.95-0.77-1.05-0.94-0.67
Upgrade
Levered Free Cash Flow
-31.4-31.31-26.68-34.78-29.85-17.88
Upgrade
Unlevered Free Cash Flow
-31.4-31.31-26.68-34.78-29.85-17.88
Upgrade
Change in Working Capital
2.023.11-0.990.731.991.4
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.